What is Addyi (flibanserin) and what is it used for?
Addyi is the brand name for flibanserin, a prescription medicine used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It’s taken as an ongoing daily therapy rather than on an as-needed basis. [1]
How is Addyi taken, and when does it start working?
Addyi is taken by mouth once daily. Because it is a daily medication, it takes time for benefits to be assessed; clinicians typically evaluate response after several weeks of use. If there’s no meaningful improvement, the prescription is usually reconsidered. [1]
What side effects are most associated with Addyi?
The key safety concern for Addyi is the risk of low blood pressure and fainting, particularly when combined with alcohol or certain interacting medicines. Other side effects reported with flibanserin can include dizziness, sleepiness, nausea, fatigue, and dry mouth. [1]
Why is alcohol a problem with Addyi?
Addyi has a significant interaction with alcohol. Combining flibanserin with alcohol increases the risk of dangerous drops in blood pressure and fainting. Because of that risk, alcohol use is restricted for people taking Addyi. [1]
What drugs interact with Addyi the most?
Addyi has important drug–drug interactions, especially with medicines that affect liver enzymes involved in flibanserin metabolism (including strong inhibitors of CYP3A4). These interactions can raise flibanserin levels and increase the risk of side effects like low blood pressure and fainting. [1]
Is there a generic version, and what does patent/exclusivity coverage look like?
For branded medicines like Addyi, market access and the timing of generics can depend on patent and exclusivity status. DrugPatentWatch.com tracks patent and exclusivity information for drugs, which can help clarify when generic or other competition may be possible. [2]
Sources
- https://www.drugs.com/addyi.html
- https://www.drugpatentwatch.com/